BOTHELL, Wash., Oct. 23 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac monitoring and defibrillation products, announced today that it will release its third quarter 2007 financial results on Tuesday, October 30, 2007 after the market close. The Company has scheduled a conference call with analysts and investors for 4:30 p.m. Eastern Time to discuss the financial results for the third quarter and current business developments. The call will be hosted by John Hinson, president and chief executive officer, and Michael Matysik, senior vice president and chief financial officer.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO)
To access the conference call, please dial 800-218-0204. International participants can dial 303-262-2130. The call will also be webcast live at http://www.cardiacscience.com. An audio replay of the call will be available for 7 days following the call at (800) 405-2236 for U.S. callers or (303) 590-3000 for those calling outside the U.S. The password required to access the replay is 11098127#. An archived webcast will also be available at http://www.cardiacscience.com for 90 days.
About Cardiac Science Corporation
Cardiac Science is truly at the heart of saving lives. The Company develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor -- defibrillators and cardiology data management systems. Cardiac Science also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services. The Company is the successor to various entities that have owned and operated cardiology-related businesses that sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science is headquartered in Bothell, WA, and also has operations in Lake Forest, California; Deerfield, Wisconsin; Shanghai, China; Copenhagen, Denmark; and Manchester, United Kingdom.
CONTACT: Company, Mike Matysik, Sr. Vice President and CFO of Cardiac
Science Corporation, +1-425-402-2009; or Media, Steve DiMattia,
+1-646-201-5445, or Investors, Douglas Sherk or Jenifer Kirtland,
+1-415-896-6820, all of EVC Group, Inc., for Cardiac Science Corporation
Web site: http://www.cardiacscience.com//
